3243-40-1

Basic information

• Product Name: 3-(4-PROPOXYPHENYL)PROPIONIC ACID
• Synonyms: 3-(4-PROPOXYPHENYL)PROPIONIC ACID;3-(4-n-Propoxyphenyl)propionic acid, 96%;4-Propoxy-benzenepropanoic acid;3-(4-propoxyphenyl)propanoic acid
• CAS NO: 3243-40-1
• Molecular Formula: C₁₂H₁₆O₃
• Molecular Weight: 208.26
• Mol File: 3243-40-1.mol

Chemical Properties

• Melting Point: 94-99℃
• Boiling Point: 345.1±17.0 °C(Predicted)
• Appearance: /
• Density: 1.093±0.06 g/cm3(Predicted)
• Storage Temp.: Sealed in dry,Room Temperature
• PKA: 4.72±0.10(Predicted)
• CAS DataBase Reference: 3-(4-PROPOXYPHENYL)PROPIONIC ACID(CAS DataBase Reference)
• NIST Chemistry Reference: 3-(4-PROPOXYPHENYL)PROPIONIC ACID(3243-40-1)
• EPA Substance Registry System: 3-(4-PROPOXYPHENYL)PROPIONIC ACID(3243-40-1)

Safety Data

• Hazardous Substances Data: 3243-40-1(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
3-(4-PROPOXYPHENYL)PROPIONIC ACID is used as an analgesic and anti-inflammatory agent for the treatment of various conditions, including arthritis and menstrual pain. It works by inhibiting the production of inflammatory mediators such as prostaglandins, thereby reducing pain and inflammation.
Used in Medication Formulation:
3-(4-PROPOXYPHENYL)PROPIONIC ACID is used as an active pharmaceutical ingredient in the formulation of tablets or capsules, which are typically administered orally. The dosage of this medication depends on the specific condition being treated and should be determined under the supervision of a healthcare professional.

Upstream product

• 5736-85-6 4-propoxybenzaldehyde 
• 1330046-68-8 3-(4-propoxyphenyl)propionic acid methyl ester 
• 90925-43-2 4-n-propyloxybenzyl alcohol 
• 2606-58-8 1-(bromomethyl)-4-propoxybenzene 
• 105-53-3 diethyl malonate 
• 69033-81-4 (E)-3-(4-propoxyphenyl)acrylic acid 

Downstream Products

• 858218-16-3 3-(4-propoxy-phenyl)-propionyl chloride 

Relevant articles and documents

PHENYLALKYLCARBOXYLIC ACID DELIVERY AGENTS

The present invention provides phenylalkylcarboxylic acid compounds and compositions containing such compounds which facilitate the delivery of biologically active agents.

Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same

The invention relates to compounds of the formula 1 and to pharmaceutically acceptable salts, solvates, prodrugs and metabolites thereof, wherein W, Z, R1 and R2, are as defined herein. The invention also relates to methods of treating Hepatitis C virus in mammals by administering the compounds of formula 1, and to pharmaceutical compositions for treating such disorders, which contain the compounds of formula 1. The invention also relates to methods of preparing the compounds of formula 1.

INHIBITORS OF HEPATITIS C VIRUS RNA-DEPENDENT RNA POLYMERASE, AND COMPOSITIONS AND TREATMENTS USING THE SAME

The invention relates to compounds of the formula (I) and to pharmaceutically acceptable salts, solvates, prodrugs and metabolites thereof, wherein W, Z, R1and R2, are as defined herein. The invention also relates to methods of treating Hepatitis C virus in mammals by administering the compounds of formula (I), and to pharmaceutical compositions for treating such disorders, which contain the compounds of formula (I). The invention also relates to methods of preparing the compounds of formula (I).